Log In
Print
BCIQ
Print
Print this Print this
 

CicloMulsion

  Manage Alerts
Collapse Summary General Information
Company NeuroVive Pharmaceutical AB
DescriptionCremophor-free IV cyclosporine formulation
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacrocycle
Latest Stage of DevelopmentPhase III
Standard IndicationIschemia / reperfusion injury
Indication DetailsPrevent ischemia/reperfusion injury in patients undergoing percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI)
Regulatory Designation

Partner

Sihuan Pharmaceutical Holdings Group Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today